Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002092.SZ Stock Summary
Top 10 Correlated ETFs
002092.SZ
In the News
002092.SZ Financial details
Company Rating
-
Market Cap
17.15B
Income
-50.19M
Revenue
51.61B
Book val./share
9.87
Cash/share
3.12
Dividend
0.1
Dividend %
1.52%
Employees
23.11K
Optionable
No
Shortable
Yes
Earnings
26 Oct 2023
P/E
-22.42
Forward P/E
28.57
PEG
2.02
P/S
0.46
P/B
0.66
P/C
2.11
P/FCF
-4.04
Quick Ratio
0.61
Current Ratio
0.75
Debt / Equity
0.87
LT Debt / Equity
0.41
-
-
EPS (TTM)
-0.13
EPS next Y
0.23
EPS next Q
-
EPS this Y
-76.27%
EPS next Y
-276.92%
EPS next 5Y
-276.92%
EPS last 5Y
-23.66%
Revenue last 5Y
-4.46%
Revenue Q/Q
-27.55%
EPS Q/Q
-
-
-
-
-
SMA20
1.84%
SMA50
-7.26%
SMA100
3.59%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-3%
ROC
-0.02%
Gross Margin
10%
Oper. Margin
-2%
Profit Margin
-2%
Payout
-99%
Shs Outstand
2.59B
Shs Float
1.69B
-
-
-
-
Target Price
-
52W Range
6.04-9.36
52W High
-27%
52W Low
+9.5%
RSI
44.74
Rel Volume
0.41
Avg Volume
22.77M
Volume
9.23M
Perf Week
-2.38%
Perf Month
1.39%
Perf Quarter
-7.2%
Perf Half Y
-2.67%
-
-
-
-
Beta
0.805
-
-
Volatility
0.04%, 0.17%
Prev Close
-0.76%
Price
6.57
Change
-0.45%
002092.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 31.31 | 38.72 | 39.21 | 26.86 | 21.71 | |
Net income per share | 1.08 | 0.16 | 0.07 | 1.16 | 0.28 | |
Operating cash flow per share | 2.85 | 3.82 | 3.29 | 1.92 | 2.07 | |
Free cash flow per share | 0.95 | 1.57 | 2.37 | 1.21 | 0.01 | |
Cash per share | 1.63 | 2.11 | 2.4 | 2.06 | 3.15 | |
Book value per share | 8.44 | 8.8 | 8.78 | 10.85 | 9.99 | |
Tangible book value per share | 8.47 | 9.74 | 9.58 | 12.76 | 12.11 | |
Share holders equity per share | 8.44 | 8.8 | 8.78 | 10.85 | 9.99 | |
Interest debt per share | 11.11 | 10.08 | 9.95 | 8.39 | 7.86 | |
Market cap | 15.18B | 14.58B | 13.21B | 22.18B | 19.22B | |
Enterprise value | 35.37B | 30.38B | 28.28B | 35.62B | 30.18B | |
P/E ratio | 6.25 | 42.48 | 90.49 | 8.21 | 26.91 | |
Price to sales ratio | 0.22 | 0.18 | 0.16 | 0.36 | 0.34 | |
POCF ratio | 2.37 | 1.78 | 1.87 | 4.98 | 3.61 | |
PFCF ratio | 7.11 | 4.31 | 2.6 | 7.9 | 698.22 | |
P/B Ratio | 0.8 | 0.77 | 0.7 | 0.88 | 0.75 | |
PTB ratio | 0.8 | 0.77 | 0.7 | 0.88 | 0.75 | |
EV to sales | 0.5 | 0.37 | 0.34 | 0.57 | 0.54 | |
Enterprise value over EBITDA | 6.04 | 8.41 | 8.5 | 4.83 | 5.68 | |
EV to operating cash flow | 5.53 | 3.7 | 4.01 | 7.99 | 5.67 | |
EV to free cash flow | 16.58 | 8.99 | 5.57 | 12.69 | 1.1K | |
Earnings yield | 0.16 | 0.02 | 0.01 | 0.12 | 0.04 | |
Free cash flow yield | 0.14 | 0.23 | 0.38 | 0.13 | 0 | |
Debt to equity | 1.26 | 1.08 | 1.07 | 0.72 | 0.74 | |
Debt to assets | 0.41 | 0.34 | 0.32 | 0.25 | 0.24 | |
Net debt to EBITDA | 3.45 | 4.38 | 4.53 | 1.82 | 2.06 | |
Current ratio | 0.76 | 0.69 | 0.65 | 0.75 | 0.7 | |
Interest coverage | 2.78 | 0.31 | 0.17 | 2.75 | 1.22 | |
Income quality | 2.5 | 42.86 | -163.63 | 1.48 | 4.86 | |
Dividend Yield | 0.11 | 0.11 | 0.09 | 0.05 | 0.07 | |
Payout ratio | 0.71 | 4.83 | 8.19 | 0.41 | 1.77 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0.01 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.67 | -0.59 | -0.28 | -0.37 | -0.99 | |
Capex to revenue | -0.06 | -0.06 | -0.02 | -0.03 | -0.09 | |
Capex to depreciation | -2.62 | -2.73 | -1.01 | -0.72 | -1.97 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 14.34 | 5.63 | 3.66 | 16.84 | 7.9 | |
ROIC | 0.06 | 0 | 0 | 0.07 | 0.03 | |
Return on tangible assets | 0.04 | 0.01 | 0 | 0.04 | 0.01 | |
Graham Net | -10.44 | -11.41 | -12.49 | -10.47 | -11.27 | |
Working capital | -6.83B | -8.48B | -11.09B | -7.63B | -10.07B | |
Tangible asset value | 19.01B | 20.92B | 20.58B | 29.68B | 31.2B | |
Net current asset value | -17.8B | -19.35B | -21.87B | -18.46B | -23.84B | |
Invested capital | 1.26 | 1.08 | 1.07 | 0.72 | 0.74 | |
Average receivables | 12.43B | 12.18B | 11.67B | 13.97B | 13.23B | |
Average payables | 7.18B | 9.2B | 10.93B | 9.79B | 10.38B | |
Average inventory | 2.79B | 2.96B | 2.51B | 2.33B | 3.13B | |
Days sales outstanding | 72.18 | 46.02 | 55.76 | 88.1 | 74.25 | |
Days payables outstanding | 45.49 | 50.11 | 51.64 | 56.73 | 92.32 | |
Days of inventory on hand | 16.44 | 14.68 | 8.77 | 18.64 | 26.14 | |
Receivables turnover | 5.06 | 7.93 | 6.55 | 4.14 | 4.92 | |
Payables turnover | 8.02 | 7.28 | 7.07 | 6.43 | 3.95 | |
Inventory turnover | 22.2 | 24.87 | 41.63 | 19.58 | 13.96 | |
ROE | 0.13 | 0.02 | 0.01 | 0.11 | 0.03 | |
Capex per share | -1.9 | -2.25 | -0.92 | -0.71 | -2.06 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.82 | 0 | 0 | 0 | 4.16 | |
Net income per share | 0.17 | 0 | 0 | 0 | -0.13 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | -0.26 | 0 | 0 | 0 | -0.4 | |
Cash per share | 2 | 0 | 0 | 0 | 3.12 | |
Book value per share | 9.97 | 0 | 0 | 0 | 9.87 | |
Tangible book value per share | 11.72 | 0 | 0 | 0 | 11.94 | |
Share holders equity per share | 9.97 | 0 | 0 | 0 | 9.87 | |
Interest debt per share | 7.69 | 0 | 0 | 0 | 8.63 | |
Market cap | 23.26B | 0 | 0 | 0 | 18.67B | |
Enterprise value | 37.63B | 11.79B | 12.85B | 10.96B | 32.62B | |
P/E ratio | 13.15 | 0 | 0 | 0 | -14.5 | |
Price to sales ratio | 1.55 | 0 | 0 | 0 | 1.74 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | -34.12 | 0 | 0 | 0 | -17.91 | |
P/B Ratio | 0.91 | 0 | 0 | 0 | 0.73 | |
PTB ratio | 0.91 | 0 | 0 | 0 | 0.73 | |
EV to sales | 2.51 | 0.82 | 1.09 | 0.74 | 3.05 | |
Enterprise value over EBITDA | 40.95 | 8.46 | 30.96 | -106.16 | -171.37 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | -55.19 | -8.14 | -8.79 | -6.42 | -31.29 | |
Earnings yield | 0.02 | 0 | 0 | 0 | -0.02 | |
Free cash flow yield | -0.03 | 0 | 0 | 0 | -0.06 | |
Debt to equity | 0.76 | 0.72 | 0.78 | 0.74 | 0.87 | |
Debt to assets | 0.25 | 0.24 | 0.25 | 0.24 | 0.27 | |
Net debt to EBITDA | 15.63 | 8.46 | 30.96 | -106.16 | -73.3 | |
Current ratio | 0.81 | 0.71 | 0.78 | 0.7 | 0.75 | |
Interest coverage | 2.06 | 3.82 | 0.29 | -1.41 | -1.77 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0.01 | 0 | 0 | 0 | 0.01 | |
Payout ratio | 0.55 | 0.76 | 30.82 | -0.44 | -0.8 | |
Sales general and administrative to revenue | 0.02 | -0.02 | 0.08 | -0.05 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0.02 | 0.01 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.05 | -0.1 | -0.12 | -0.12 | -0.1 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 6.21 | 0 | 0 | 0 | 5.27 | |
ROIC | 0.01 | 0.02 | 0 | -0.01 | -0.01 | |
Return on tangible assets | 0.01 | 0.01 | 0 | -0.01 | 0 | |
Graham Net | -9.84 | 0 | 0 | 0 | -11.7 | |
Working capital | -6.44B | -9.49B | -7.83B | -10.07B | -8.39B | |
Tangible asset value | 30.18B | 31.13B | 31.23B | 31.2B | 30.75B | |
Net current asset value | -18.48B | -21.62B | -22.23B | -23.84B | -24.31B | |
Invested capital | 0.76 | 0.72 | 0.78 | 0.74 | 0.87 | |
Average receivables | 16.35B | 14.99B | 13.85B | 13.35B | 12.04B | |
Average payables | 9.23B | 11.31B | 12.75B | 12.69B | 11.99B | |
Average inventory | 3B | 3.42B | 3.74B | 3.7B | 3.78B | |
Days sales outstanding | 105.65 | 77.62 | 117.05 | 69.27 | 106.87 | |
Days payables outstanding | 68.76 | 94.27 | 113.82 | 82.02 | 106.03 | |
Days of inventory on hand | 22.1 | 27.12 | 34.07 | 23.22 | 37.12 | |
Receivables turnover | 0.85 | 1.16 | 0.77 | 1.3 | 0.84 | |
Payables turnover | 1.31 | 0.95 | 0.79 | 1.1 | 0.85 | |
Inventory turnover | 4.07 | 3.32 | 2.64 | 3.88 | 2.42 | |
ROE | 0.02 | 0.03 | 0 | -0.02 | -0.01 | |
Capex per share | -0.26 | 0 | 0 | 0 | -0.4 |
002092.SZ Frequently Asked Questions
What is Xinjiang Zhongtai Chemical Co., Ltd. stock symbol ?
Xinjiang Zhongtai Chemical Co., Ltd. is a CN stock and trading under the symbol 002092.SZ
What is Xinjiang Zhongtai Chemical Co., Ltd. stock quote today ?
Xinjiang Zhongtai Chemical Co., Ltd. stock price is $6.57 today.
Is Xinjiang Zhongtai Chemical Co., Ltd. stock public?
Yes, Xinjiang Zhongtai Chemical Co., Ltd. is a publicly traded company.